- A blank check company formed by Vedanta Management, Eucrates Biomedical Acquisition (EUCRU) has priced its initial public offering of 10M units at $10/unit.
- Trading commenced today on Nasdaq.
- Each unit consists of one ordinary share and one-third of one redeemable warrant to purchase one ordinary share at $11.50.
- Underwriters' over-allotment is an additional 1.5M units.
- Press release
- https://seekingalpha.com/news/3625378-eucrates-biomedical-acquisition-prices-100m-ipo
Friday, October 23, 2020
Eucrates Biomedical Acquisition prices $100M IPO
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.